Successful brentuximab vedotin and nivolumab therapy of multiply refractory diffuse large B-cell lymphoma with Hodgkin features

MeSH terms

• Brentuximab Vedotin
• Hodgkin Disease* / diagnosis
• Hodgkin Disease* / drug therapy
• Hodgkin Disease* / pathology
• Humans
• Immunoconjugates* / therapeutic use
• Lymphoma, Large B-Cell, Diffuse* / diagnosis
• Lymphoma, Large B-Cell, Diffuse* / drug therapy
• Lymphoma, Non-Hodgkin*
• Nivolumab / therapeutic use